• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤患者的全身细胞因子环境会发生永久性改变。

The systemic cytokine environment is permanently altered in multiple myeloma.

机构信息

Department of Biological Sciences, Purdue University, West Lafayette, Indiana, United States of America.

出版信息

PLoS One. 2013;8(3):e58504. doi: 10.1371/journal.pone.0058504. Epub 2013 Mar 27.

DOI:10.1371/journal.pone.0058504
PMID:23544044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3609759/
Abstract

Multiple myeloma (MM) is an incurable bone marrow malignancy of the B cell lineage. Utilizing multiplex Luminex technology we measured levels of 25 cytokines in the plasma of normal donors (n = 177), those with monoclonal gammopathy of undetermined significance (n = 8), and MM patients (n = 55) with either active disease, on treatment, or in remission. The cytokine levels were compared between normal donors and MM patients as well as between various phases of MM, and discriminant analysis was used to create a predictive classification model based on the differentially expressed cytokines. Evaluating age- and gender-dependence of cytokine expression, we determined that with age there is a shift toward a pro-inflammatory environment. Moreover, we observed a strong gender bias in cytokine expression. However, the profile of differentially expressed cytokines was heavily skewed toward an anti-inflammatory, pro-tumorigenic response in patients with MM. Significantly, our predictive model placed all patients in remission in the same category as those with active disease. Thus, our study demonstrates that the homeostasis of systemic cytokines is not restored when MM patients enter remission, suggesting that once an individual has cancer, the microenvironment is permanently altered and the system is primed for a relapse.

摘要

多发性骨髓瘤(MM)是一种不可治愈的骨髓恶性肿瘤,属于 B 细胞系。我们利用多重 Luminex 技术测量了正常供体(n=177)、意义未明单克隆丙种球蛋白血症(n=8)和多发性骨髓瘤患者(n=55)的血浆中 25 种细胞因子的水平,这些患者的疾病处于活动期、治疗中或缓解期。我们比较了正常供体和 MM 患者之间以及 MM 各个阶段之间的细胞因子水平,并利用判别分析基于差异表达的细胞因子创建了一个预测分类模型。评估细胞因子表达的年龄和性别依赖性,我们发现随着年龄的增长,环境向促炎方向转变。此外,我们观察到细胞因子表达存在强烈的性别偏见。然而,在 MM 患者中,差异表达细胞因子的特征严重偏向抗炎、促肿瘤反应。重要的是,我们的预测模型将所有缓解期患者与活动期患者归为同一类别。因此,我们的研究表明,当 MM 患者进入缓解期时,全身细胞因子的平衡并未恢复,这表明一旦个体患有癌症,微环境就会永久改变,系统就会为复发做好准备。

相似文献

1
The systemic cytokine environment is permanently altered in multiple myeloma.多发性骨髓瘤患者的全身细胞因子环境会发生永久性改变。
PLoS One. 2013;8(3):e58504. doi: 10.1371/journal.pone.0058504. Epub 2013 Mar 27.
2
Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.意义未明单克隆丙种球蛋白血症和多发性骨髓瘤的淋巴细胞亚群和炎症细胞因子。
Int J Mol Sci. 2019 Jun 10;20(11):2822. doi: 10.3390/ijms20112822.
3
Evaluating the role of Tregs in the progression of multiple myeloma.评估调节性 T 细胞在多发性骨髓瘤进展中的作用。
Leuk Lymphoma. 2019 Sep;60(9):2134-2142. doi: 10.1080/10428194.2019.1579324. Epub 2019 Feb 18.
4
Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients.MGUS 和骨髓瘤患者单克隆 IgA 的靶标和糖基化分析。
Front Immunol. 2020 May 27;11:854. doi: 10.3389/fimmu.2020.00854. eCollection 2020.
5
The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.血清κ/λ比值对意义未明的单克隆丙种球蛋白病和多发性骨髓瘤鉴别的预测能力。
Clin Chem Lab Med. 2005;43(1):32-7. doi: 10.1515/CCLM.2005.004.
6
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.通过多维流式细胞术实现长期疾病控制的多发性骨髓瘤患者免疫系统分析。
Haematologica. 2013 Jan;98(1):79-86. doi: 10.3324/haematol.2012.067272. Epub 2012 Jul 6.
7
Circulating hepatocyte growth factor levels in multiple myeloma.多发性骨髓瘤患者循环中肝细胞生长因子水平
Br J Haematol. 2003 May;121(3):532. doi: 10.1046/j.1365-2141.2003.04321.x.
8
Differential humoral responses against heat-shock proteins after autologous stem cell transplantation in multiple myeloma.自体造血干细胞移植后多发性骨髓瘤患者对热休克蛋白的体液免疫反应差异。
Ann Hematol. 2014 Jan;93(1):107-11. doi: 10.1007/s00277-013-1942-7. Epub 2013 Nov 12.
9
Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.循环 miRNA 作为多发性骨髓瘤和意义未明的单克隆丙种球蛋白血症的诊断生物标志物。
J Clin Lab Anal. 2020 Jun;34(6):e23233. doi: 10.1002/jcla.23233. Epub 2020 Feb 10.
10
Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy.骨髓中前肿瘤性丙种球蛋白病中的干细胞样/固有 T 细胞、先天和髓样细胞的早期改变。
JCI Insight. 2019 Apr 23;5(11):127807. doi: 10.1172/jci.insight.127807.

引用本文的文献

1
Effects of mesenchymal stem cells from different sources on the biological functions of multiple myeloma cells.不同来源间充质干细胞对多发性骨髓瘤细胞生物学功能的影响。
Stem Cell Res Ther. 2025 Feb 25;16(1):89. doi: 10.1186/s13287-025-04222-8.
2
Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone.来那度胺和地塞米松治疗前后多发性骨髓瘤患者血清细胞因子的综合分析。
Cancer Med. 2024 Jul;13(14):e70019. doi: 10.1002/cam4.70019.
3
Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy.

本文引用的文献

1
[Serum level of IL-17 in patients with multiple myeloma and its clinical significance].[多发性骨髓瘤患者血清白细胞介素-17水平及其临床意义]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Aug;20(4):930-2.
2
The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation.IL-7 在 B 细胞发育中的多种作用;生存、增殖和分化的介质。
Semin Immunol. 2012 Jun;24(3):198-208. doi: 10.1016/j.smim.2012.02.001. Epub 2012 Mar 14.
3
IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7Rα.
在接受来那度胺维持治疗的多发性骨髓瘤患者中,自体造血细胞移植1年后可观察到CXCL10升高。
Bone Marrow Transplant. 2023 Aug;58(8):953-955. doi: 10.1038/s41409-023-02004-5. Epub 2023 May 6.
4
Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages.探讨联合 IL-2 激活的自然杀伤细胞与抗 PDL1 单克隆抗体靶向多发性骨髓瘤相关巨噬细胞的潜力。
Cancer Immunol Immunother. 2023 Jun;72(6):1789-1801. doi: 10.1007/s00262-022-03365-4. Epub 2023 Jan 19.
5
Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma.多发性骨髓瘤中骨髓间充质和成骨细胞的分子特征。
Int J Mol Sci. 2022 Dec 7;23(24):15448. doi: 10.3390/ijms232415448.
6
Immune senescence in multiple myeloma-a role for mitochondrial dysfunction?多发性骨髓瘤中的免疫衰老——线粒体功能障碍的作用?
Leukemia. 2022 Oct;36(10):2368-2373. doi: 10.1038/s41375-022-01653-7. Epub 2022 Jul 25.
7
Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation.宿主-微生物相互作用及其在多发性骨髓瘤和造血干细胞移植中的结果。
Cancer Metastasis Rev. 2022 Jun;41(2):367-382. doi: 10.1007/s10555-022-10033-7. Epub 2022 Apr 29.
8
Natural Killer Cells in the Malignant Niche of Multiple Myeloma.自然杀伤细胞在多发性骨髓瘤的恶性微环境中。
Front Immunol. 2022 Jan 11;12:816499. doi: 10.3389/fimmu.2021.816499. eCollection 2021.
9
Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib.硼替佐米治疗的多发性骨髓瘤患者中,白细胞介素-1受体拮抗剂和白细胞介素-4的预处理血清水平是总生存期的预测指标。
J Clin Med. 2021 Dec 26;11(1):112. doi: 10.3390/jcm11010112.
10
Aging-associated immune system changes in multiple myeloma: The dark side of the moon.多发性骨髓瘤中与衰老相关的免疫系统变化:月亮的阴暗面。
Cancer Treat Res Commun. 2021;29:100494. doi: 10.1016/j.ctarc.2021.100494. Epub 2021 Nov 20.
IL-7 驱动原发性干燥综合征患者 Th1 和 Th17 细胞因子的产生,尽管 CD4 T 细胞缺乏 IL-7Rα 的数量增加了。
Rheumatology (Oxford). 2012 Jun;51(6):996-1005. doi: 10.1093/rheumatology/ker448. Epub 2012 Feb 1.
4
Autologous stem cell transplantation and multiple myeloma cancer stem cells.自体干细胞移植与多发性骨髓瘤肿瘤干细胞。
Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S27-32. doi: 10.1016/j.bbmt.2011.10.036.
5
Inflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged people.干细胞龛的炎症衰老:以乳腺癌为例:多壳细胞因子网络的崩溃为老年人的癌症提供燃料。
Bioessays. 2012 Jan;34(1):40-9. doi: 10.1002/bies.201100104. Epub 2011 Nov 16.
6
Aging, immunity, and cancer.衰老、免疫与癌症。
Discov Med. 2011 Jun;11(61):537-50.
7
Multiple myeloma.多发性骨髓瘤
N Engl J Med. 2011 Mar 17;364(11):1046-60. doi: 10.1056/NEJMra1011442.
8
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer.肿瘤内辅助性 T 细胞 2 型浸润与癌症相关成纤维细胞胸腺基质淋巴细胞生成素的产生以及胰腺癌患者生存时间减少相关。
J Exp Med. 2011 Mar 14;208(3):469-78. doi: 10.1084/jem.20101876. Epub 2011 Feb 21.
9
Potentiation of Th17 cytokines in aging process contributes to the development of colitis.衰老过程中 Th17 细胞因子的增强导致结肠炎的发生。
Cell Immunol. 2011;266(2):208-17. doi: 10.1016/j.cellimm.2010.10.007. Epub 2010 Oct 27.
10
Age-related changes in immune function: effect on airway inflammation.与年龄相关的免疫功能变化:对气道炎症的影响。
J Allergy Clin Immunol. 2010 Oct;126(4):690-9; quiz 700-1. doi: 10.1016/j.jaci.2010.08.011.